Public Profile

INNOBIO USA

INNOBIO USA, a prominent player in the biotechnology sector, is headquartered in the United States and operates extensively across North America. Founded in 2015, the company has rapidly established itself as a leader in the development of innovative diagnostic solutions and biomarker discovery, catering to the evolving needs of the healthcare industry. Specialising in high-quality reagents and advanced diagnostic kits, INNOBIO USA distinguishes itself through its commitment to precision and reliability. The company’s core offerings include a range of immunoassays and molecular diagnostics that enhance disease detection and management. With a focus on research and development, INNOBIO USA has achieved significant milestones, positioning itself as a trusted partner in the global healthcare landscape.

DitchCarbon Score

How does INNOBIO USA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

INNOBIO USA's score of 3 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

20%

INNOBIO USA's reported carbon emissions

INNOBIO USA, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their carbon footprint or climate initiatives. However, the company may still be engaged in sustainability practices typical of the industry, focusing on reducing environmental impact and enhancing operational efficiency. As the landscape of corporate climate responsibility evolves, INNOBIO USA may consider establishing measurable targets and reporting frameworks to align with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. INNOBIO USA's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. INNOBIO USA is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

INNOBIO USA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Chemicals

Deepak Chemtex

IN
Chemicals
Updated 11 days ago

Kensing

US
Chemicals
Updated 11 days ago

Schutte Bagclosures BV

NL
Chemicals
Updated 11 days ago

Macfarlan Smith Portugal, Lda

PT
Chemicals
Updated 3 days ago

Nakao Filter Media

JP
Chemicals
Updated 11 days ago
CDP

Koster Keunen

US
Chemicals
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers